ACRX – HedgeChatter

Four Billionaire Loved Biotech Stocks That Analysts Think Will …

Four Billionaire Loved Biotech Stocks That Analysts Think Will DoubleAt Billionairesportfolio.com we actively manage a portfolio of the “best ideas” from the world’s best hedge funds, and our members get to follow along.Following the highest conviction trades of the world’s best hedge funds works especially well in the biotech sector. It gives you direct access to the smartest investment minds […]

January 29, 2015 ByBillionaires Portfolio ACRX, advisors, billionairesportfolio, capital, harvard, healthcare, infinity, orbimed, sarissa, stocks, world Comments Off read more

Four Billionaire Loved Biotech Stocks That Analysts Think Will Double

Four Billionaire Loved Biotech Stocks That Analysts Think Will DoubleAt Billionairesportfolio.com we actively manage a portfolio of the “best ideas” from the world’s best hedge funds, and our members get to follow along.Following the highest conviction trades of the world’s best hedge funds works especially well in the biotech sector. It gives you direct access to the smartest investment minds […]

January 29, 2015 ByBillionaires Portfolio ACRX, ariad, billionaire, billionairesportfolio, biotech, management, orbimed, perceptive, princeton, sarissa, stocks, world Comments Off read more

AcelRx Pharmaceuticals’ (ACRX) CEO Richard King on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Richard King Thanks Tim. I’m joined in the call today by Tim obviously, but also by Pam Palmer, Founder and Chief Medical Officer for AcelRx. moreView todays social media effects on ACRXView the latest stocks trending across Twitter. Click to view dashboardSee who AcelRx is hiring next, click here to view […]

May 9, 2014 Bystocknews ACRX, stock Comments Off read more

ACELRX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report

moreView todays social media effects on ACRXView the latest stocks trending across Twitter. Click to view dashboardSee who AcelRx is hiring next, click here to view […]